Archives

by in
Entry Author Date Location
See You Tomorrow at New York’s Life Science Disruptors 03/05/14 New York
New York’s Life Science Disruptors on March 6: Here’s the Agenda 02/26/14 New York
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
East Coast Biotech Roundup: Dicerna, J&J, Neurophage, & More 01/31/14 Boston
Eric Schadt, Acorda’s Cohen Join NY’s Life Science Disruptors Lineup 01/30/14 New York
Epizyme Heads Back to Wall Street, Plans $140M Raise 01/27/14 Boston
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Join Us, And New York’s “Life Science Disruptors,” On March 6 01/23/14 New York
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
The Big Guys Have Lost Their Iron Grip, and It’s All Good 01/20/14 National
Alkermes Nabs $250M It Doesn’t Need, But Could Fend Off Barbarians 01/13/14 Boston
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
Atara Biotherapeutics Lands $13,500,000 Series B Round 01/10/14 San Diego
Atara Biotherapeutics Receives $38,500,000 Series B Financing 12/18/13 San Diego
Atara Bio Grabs $38.5M to Help Kidney Patients, Fight Cancer 12/17/13 San Francisco
East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More 12/13/13 Boston
Sutro Biopharma Garners $26,000,000 Series D Funding 12/11/13 San Francisco
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
NYCEDC Amassing $100M Biotech Fund; Boehringer Jumps Into Kendall Square 12/04/13 New York
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell Drugs 12/03/13 San Francisco
3 Life Sciences Companies That Are Built to Last 12/02/13 National
How Alkermes Survived a Brush With Death 11/11/13 National
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
Clovis Oncology CEO Mahaffy Opens Up About Company’s Turbulent Year 10/17/13 Boulder/Denver
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
San Diego Life Sciences Roundup: Tandem Diabetes, Ligand, and More 10/10/13 San Diego
Page 2 of 8 « previous page · next page »